{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:54:11Z","timestamp":1776704051929,"version":"3.51.2"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1093\/mmy\/myx011","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T03:56:16Z","timestamp":1487130976000},"page":"803-812","source":"Crossref","is-referenced-by-count":24,"title":["Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study"],"prefix":"10.1093","volume":"55","author":[{"given":"Juergen","family":"Prattes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Buzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederike","family":"Reischies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Koidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zollner-Schwetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"key\n\t\t\t\t20171005101930_bib1","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171005101930_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171005101930_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","article-title":"Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"19","year":"2015","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20171005101930_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/TP.0000000000000153","article-title":"Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study","volume":"98","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171005101930_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","article-title":"Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality","volume":"59","year":"2004","journal-title":"Acta Clin Belg"},{"key":"key\n\t\t\t\t20171005101930_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2011.23.5.290","article-title":"Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience","volume":"23","year":"2011","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20171005101930_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","year":"2011","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171005101930_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2143\/ACB.3408","article-title":"Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years","volume":"68","year":"2013","journal-title":"Acta Clin Belg"},{"key":"key\n\t\t\t\t20171005101930_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MAJ.0b013e318068d79c","article-title":"Non-decompensated cirrhosis as a risk factor for invasive aspergillosis: a case report and review of the immune dysfunction of cirrhosis","volume":"334","year":"2007","journal-title":"Am J Med Sci"},{"key":"key\n\t\t\t\t20171005101930_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-7-2","article-title":"Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series","volume":"7","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"key\n\t\t\t\t20171005101930_bib11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171005101930_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","article-title":"Aspergillus fumigatus and aspergillosis","volume":"12","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171005101930_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1056\/NEJM199410273311704","article-title":"Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171005101930_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/315742","article-title":"In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease","volume":"182","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20171005101930_bib16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/591458","article-title":"Human platelets attenuate Aspergillus species via granule-dependent mechanisms","volume":"198","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171005101930_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejrad.2005.01.001","article-title":"Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?","volume":"55","year":"2005","journal-title":"Eur J Radiol"},{"key":"key\n\t\t\t\t20171005101930_bib20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib21","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jac\/dks155","article-title":"European Organization for the Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) host factors and invasive fungal infections in patients with haematological malignancies","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171005101930_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171005101930_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","article-title":"Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases","volume":"190","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171005101930_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","year":"1998","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20171005101930_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171005101930_bib26","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171005101930_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171005101930_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","article-title":"Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test","volume":"46","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171005101930_bib30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1440-1843.2012.02283.x","article-title":"Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects","volume":"18","year":"2013","journal-title":"Respirology"},{"key":"key\n\t\t\t\t20171005101930_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171005101930_bib33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171005101930_bib34","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/17425255.2011.627854","article-title":"Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450","volume":"7","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key\n\t\t\t\t20171005101930_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.amjmed.2015.10.029","article-title":"Oral azole antifungal medications and risk of acute liver injury, overall and by chronic liver disease status","volume":"129","year":"2016","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171005101930_bib36","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.00251-13","article-title":"Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171005101930_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171005101930_bib38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/myc.12477","article-title":"Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections","volume":"59","year":"2016","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20171005101930_bib39","first-page":"635","article-title":"Impact of pre-analytical variables in the determination of serum galactomannan","volume":"55","year":"2017","journal-title":"Med Mycol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/55\/8\/803\/20589878\/myx011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T14:07:15Z","timestamp":1568815635000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/mmy\/article\/55\/8\/803\/3745326\/Invasive-aspergillosis-in-patients-with-underlying"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,4,20]]},"published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myx011","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}